🟢 TEM is trading 5.4% up today after announcing validation wins for its Cardiac AI diagnostics platform

TEM is trading 5.4% up today at $45.98 after the company announced significant validation wins for its Cardiac AI diagnostics platform across regulatory and commercial fronts.

• The company highlighted its strong financial performance, with $1.2 billion in revenue for full-year 2025 and 2026 guidance of approximately $1.59 billion in revenue and $65 million in adjusted EBITDA.
• This guidance projects Tempus's first year of positive adjusted profitability, providing a fundamental catalyst for the stock's upward movement.